German National Authority/ Regulatory agency, (Federal Institute for Drugs and Medical Devices, Bundesinstitut für Arzneimittel und Medizinprodukte). Amongst other tasks, the BfArM is responsible for drugs and medical devices, including the approval of clinical studies, that do not fall into the area of expertise of the PEI (Paul-Ehrlich-Institut).